当前位置:首页 - 行情中心 - 易明医药(002826) - 财务分析 - 现金流量表

易明医药

(002826)

  

流通市值:32.49亿  总市值:33.54亿
流通股本:1.85亿   总股本:1.91亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金414,886,173.52213,713,764.53740,991,846.73556,124,028.43
  收到的税费返还--1,745.95-
  收到其他与经营活动有关的现金29,644,250.211,155,820.9840,786,496.0443,876,680.71
  经营活动现金流入小计444,530,423.73214,869,585.51781,780,088.72600,000,709.14
  购买商品、接受劳务支付的现金61,326,576.924,632,881.78119,463,271.4579,027,480.81
  支付给职工以及为职工支付的现金63,984,414.0928,054,288.3183,370,767.3854,125,263.75
  支付的各项税费53,443,923.6224,602,245.5198,064,359.8769,766,770.61
  支付其他与经营活动有关的现金91,819,567.5358,210,388.91357,161,524.23247,483,199.14
  经营活动现金流出小计270,574,482.14135,499,804.51658,059,922.93450,402,714.31
  经营活动产生的现金流量净额173,955,941.5979,369,781123,720,165.79149,597,994.83
二、投资活动产生的现金流量:
  收回投资收到的现金880,000,000200,000,000714,000,000434,000,000
  取得投资收益收到的现金1,775,874.79215,833.343,503,648.941,610,335.98
  处置固定资产、无形资产和其他长期资产收回的现金净额186,000186,000150,218.06169,380
  收到的其他与投资活动有关的现金--3,005,174.13-
  投资活动现金流入小计881,961,874.79200,401,833.34720,659,041.13435,779,715.98
  购建固定资产、无形资产和其他长期资产支付的现金1,459,740.24818,138.918,495,636.165,509,804.62
  投资支付的现金1,110,000,000400,000,000714,000,000714,000,000
  投资活动现金流出小计1,111,459,740.24400,818,138.91722,495,636.16719,509,804.62
  投资活动产生的现金流量净额-229,497,865.45-200,416,305.57-1,836,595.03-283,730,088.64
三、筹资活动产生的现金流量:
  取得借款收到的现金28,800,000-22,108,171.3922,108,171.39
  收到其他与筹资活动有关的现金28,644,00028,644,00024,510,00024,510,000
  筹资活动现金流入小计57,444,00028,644,00046,618,171.3946,618,171.39
  偿还债务支付的现金11,249,841.6911,249,841.6933,657,536.6618,138,329.7
  分配股利、利润或偿付利息支付的现金28,522,362.2136,811.9823,843,512.1623,675,400.52
  筹资活动现金流出小计39,772,203.911,286,653.6757,501,048.8241,813,730.22
  筹资活动产生的现金流量净额17,671,796.117,357,346.33-10,882,877.434,804,441.17
四、汇率变动对现金及现金等价物的影响-457,296.9-418,483.11-734,015.58-387,406.55
五、现金及现金等价物净增加额-38,327,424.66-104,107,661.35110,266,677.75-129,715,059.19
  加:期初现金及现金等价物余额537,664,815.13537,664,815.13427,398,137.38427,398,137.38
  期末现金及现金等价物余额499,337,390.47433,557,153.78537,664,815.13297,683,078.19
补充资料:
  净利润66,679,694.56-93,124,133.45-
  资产减值准备435,423.75-1,531,500.61-
  固定资产和投资性房地产折旧8,120,128.76-17,413,624.13-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧8,120,128.76-17,413,624.13-
  无形资产摊销384,138.65-1,722,713.28-
  处置固定资产、无形资产和其他长期资产的损失87,487.98-231,318.41-
  固定资产报废损失21,079.09-29,891.21-
  财务费用116,866.29-120,423.33-
  投资损失-1,739,655.7--3,496,674.69-
  递延所得税132,428.83--1,834,834.4-
  其中:递延所得税资产减少132,428.83--1,834,834.4-
  存货的减少5,766,107.69--18,735,945.11-
  经营性应收项目的减少69,529,176.39-26,549,692.58-
  经营性应付项目的增加24,423,065.3-8,842,106.33-
  其他---1,777,783.34-
  现金的期末余额499,337,390.47-537,664,815.13-
  减:现金的期初余额537,664,815.13-427,398,137.38-
  现金及现金等价物的净增加额-38,327,424.66-110,266,677.75-
公告日期2026-08-272026-04-282026-04-282025-10-29
审计意见(境内)标准无保留意见
TOP↑